Catalent (CTLT) Tops Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Catalent, Inc. Reports First Quarter Fiscal 2018 Results
November 6, 2017 7:30 AM ESTQ1'18 revenue of $543.9 million increased 23% as-reported, or 22% in constant currency from the prior-year period. Announced and closed the acquisition of Cook Pharmica, a privately held, biologics-focused contract development and manufacturing organization. Issued 8-year $450 million, 4.875% coupon, USD senior notes with proceeds used to fund the Cook Pharmica acquisition; concurrently re-priced and extended our term loans (USD tranche 50 bps and EUR tranche 75 bps lower). FY18 guidance updated to reflect acquisition.
SOMERSET, N.J.--(BUSINESS WIRE)--... More
